A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Biomerics Expands Operations in Costa Rica and Breaks Ground On a 110,000 sq. ft. New Facility

February 15, 2021

Biomerics announced it is doubling its manufacturing footprint in the La Zeta Free Trade Zone in Cartago, Costa Rica.

The company held a joint groundbreaking ceremony with La Zeta and CINDE on Friday, February 12, 2021. (Biomerics is a mid-market medical device contract manufacturer).

The expansion is via a new greenfield plant adjacent to Biomerics current operations and includes extrusion, injection molding, micro metal processing, and cleanroom assembly process. The new facility construction totaling 110,000 sq. ft. will reflect Biomerics vertically integrated, full-service business model and will include engineering labs, quality inspection labs, controlled environment manufacturing, office space, class 7 clean rooms, packaging, and warehouse facilities.

Biomerics currently employs 175 people at its 50,000 sq. ft. facility focused on extrusion, laser processing, high volume assembly, and packaging. The expansion is in support of active transfer programs with strategic customers and is expected to double its number of Costa Rican employees over the next three years.

Biomerics, Travis Sessions
Biomerics, Travis Sessions

“This expansion is in line with our vision to be the leading interventional contract manufacturer,” stated Travis Sessions, company. CEO. “Customers have requested that we build a vertically integrated operation in Costa Rica to provide cost-effective high volume manufacturing for the interventional market.”

“We are excited for the value that this expansion brings to our existing customer base in Costa Rica and interventional OEM partners around the globe,” stated Chris Richardson, Biomerics Director of Sales and Marketing. “The thriving medical device ecosystem in Costa Rica aligns well with Biomerics’ culture and innovative core.”

Construction is expected to be completed by Q4 2021 and will be celebrated with an open house.

SourceBiomerics
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Serum Detect is developing diagnostic tests, using standard liquid biopsy samples, that complement and enhance existing screening techniques for early detection of cancer.
The company announced the launch of validated antibodies for rare cell and circulating tumor cell (CTC) enumeration. Validated for use with Bio-Rad’s Celselect Slides Enumeration Stain Kits, the antibodies are specific to CTC surface markers to enable the sensitive and specific identification of target cell populations, enhancing the study of tumor heterogeneity and disease progression at various stages.
Proteintech advises the new building houses research and development, production, logistics and administration in an area more than three times larger than its previous space.
In September 2023, Seegene and Springer Nature opened applications to scientists and experts across the global community to conduct research for the 15 designated projects to develop Seegene's syndromic qPCR diagnostics assay reagents for the Open Innovation Program.
Lindus Health has taken learnings from this experience to build a bespoke "All-in-One Metabolic CRO" offering that combines the expertise of a seasoned full service CRO and internal site/PI expertise with a distinctive technology driven approach on its proprietary Citrusâ„¢ platform. This unique marriage of technology and services sets metabolic sponsors up to run faster, more patient-centric clinical trials.

By using this website you agree to accept Medical Device News Magazine Privacy Policy